Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brines

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxiaMonica Fantacci, Paola Bianciardi, Anna Caretti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Electrical stimulation of the dorsal motor nucleus of the vagus regulates inflammation without affecting the heart rateAidan Falvey, Santhoshi P Palandira, Sangeeta S Chavan, et al.
Journal of Cardiovascular Development and Disease|June 25, 2026
Combination Therapy with Bisoprolol and Tissue Protective Molecule ARA 284 Is Cardio-Protective and Improves Survival in Experimental Cancer CachexiaMasatsugu Okamura, Sandra Palus, Wolfram Döehner, et al.
Transplantation|December 20, 2015
A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted IsletsMasaaki Watanabe, Torbjörn Lundgren, Yu Saito, et al.
Experimental Neurology|August 30, 2011
Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic gangliaRobert E Schmidt, Dongyan Feng, Qiuling Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinHiroto Ueba, Michael Brines, Michael Yamin, et al.
Molecular Pain|February 18, 2014
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia responseMaarten Swartjes, Monique van Velzen, Marieke Niesters, et al.
Diabetes|September 14, 2011
Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathyCarmel M McVicar, Ross Hamilton, Liza M Colhoun, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2003
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodelingLaura Calvillo, Roberto Latini, Jan Kajstura, et al.
Scientific Reports|March 18, 2018
Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathyMichael Brines, Daniel A Culver, Maryam Ferdousi, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxiaMonica Fantacci, Paola Bianciardi, Anna Caretti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Electrical stimulation of the dorsal motor nucleus of the vagus regulates inflammation without affecting the heart rateAidan Falvey, Santhoshi P Palandira, Sangeeta S Chavan, et al.
Journal of Cardiovascular Development and Disease|June 25, 2026
Combination Therapy with Bisoprolol and Tissue Protective Molecule ARA 284 Is Cardio-Protective and Improves Survival in Experimental Cancer CachexiaMasatsugu Okamura, Sandra Palus, Wolfram Döehner, et al.
Transplantation|December 20, 2015
A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted IsletsMasaaki Watanabe, Torbjörn Lundgren, Yu Saito, et al.
Experimental Neurology|August 30, 2011
Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic gangliaRobert E Schmidt, Dongyan Feng, Qiuling Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinHiroto Ueba, Michael Brines, Michael Yamin, et al.
Molecular Pain|February 18, 2014
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia responseMaarten Swartjes, Monique van Velzen, Marieke Niesters, et al.
Diabetes|September 14, 2011
Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathyCarmel M McVicar, Ross Hamilton, Liza M Colhoun, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2003
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodelingLaura Calvillo, Roberto Latini, Jan Kajstura, et al.
Scientific Reports|March 18, 2018
Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathyMichael Brines, Daniel A Culver, Maryam Ferdousi, et al.
Pageof 12